Skip to content

Effects of Physical Exercise on Sarcopenia After Bariatric Surgery

Effects of Physical Exercise on Sarcopenia After Bariatric Surgery: Protocol of a Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05289219
Acronym
EXPOBAR
Enrollment
60
Registered
2022-03-21
Start date
2021-09-01
Completion date
2023-12-31
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Sarcopenic Obesity

Keywords

bariatric surgery, quality of life, metabolic risk factors,, fat-free mass, sarcopenia, exercise

Brief summary

The study will include 60 patients awaiting bariatric surgery. They will be randomized into 2 groups, experimental and control. The intervention will take place 1 month after surgery, for a total of 16 weeks. Parameters of body composition, metabolic risk, quality of life, physical activity and sedentary behavior will be determined

Detailed description

Bariatric surgery is the treatment of severe obesity with associated pathologies, with proven evidence in its benefits. Treating overweight allows a better and even reversal of pathologies associated with obesity. In this context, we know that physical exercise is important in the process of weight loss, however, and especially in bariatric surgery, the characteristics of physical activity are not consensual, as well as the effect of programs and physical exercise in this population. Weight loss associated with bariatric surgery is greatly associated with a significant reduction of skeletal muscle and bone mineral mass, which leads us to induce that after bariatric surgery, patients incur an increased risk of sarcopenia. The need for prophylactic programs that prevent sarcopenia in bariatric surgery patients seems to be one of the crucial points for the framing of long-term surgical success of bariatric and metabolic surgery. This randomized clinical trial will aim to study the effects of a 16-week supervised exercise intervention program on the prevention of sarcopenia after bariatric surgery This randomized controlled trial study will include 60 patients of both sexes on the waiting list for bariatric surgery and who have subsequently performed the surgery. They will be randomized into 2 groups, experimental and control. The intervention will take place 1 month after surgery, for a total of 16 weeks. Parameters of body composition, metabolic risk, quality of life, physical activity, and sedentary behavior will be determined. Assessments will take place in five moments, the surgery, the intervention, the post-intervention, six months after the intervention, twelve months after the intervention.

Interventions

BEHAVIORALEXPOBAR

Each session will start with 5 minutes of warm-up and finalization with 10 minutes of a cool-down, with work of flexibility and proprioception. The maintenance of balance and postural stability may be compromised in obese individuals, depending on the degree of obesity, although the support base provided by the position of the foot is proportional to the structural morphology of each subject. Flexibility is also gradually impaired in obese individuals and of course, these changes may be related to postural changes aggravated by a sedentary lifestyle and biological aging itself alongside all metabolic alterations inherent to the pathology of obesity (Benetti et al., 2016). And the warm-up and the cool-down will be developed as the component of training with the evolution by phases, both in time and in intensity. The first phase will include 20 minutes of interval training, encompassing circuit strength training. Each phase will have an increment of 10 minutes in the central block.

Sponsors

University of Évora
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Randomization is performed using a random selection method from the waiting list and the data will be coded and transferred to the database, depending on the intervention group and control group. Data analysis will be done statistically. Each participant will be randomly assigned to each group after signing the informed consent and conducting the initial assessments. All laboratory samples and data collected will be identified with identification ID, safeguarding the confidentiality of the collected data. At the end of this study, all participants of the control group will be offered the same intervention as the exercise group.

Intervention model description

randomized controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* As inclusion criteria, patients should be enrolled for bariatric surgery at the hospital * Aged between 18 years and 60 years * Contraindication to the practice of exercise * Agree to participate in the study

Exclusion criteria

* Patients with problems in locomotion * Surgical complications * Psychiatric diseases and neurological disorders

Design outcomes

Primary

MeasureTime frameDescription
Cardiorespiratory1 yearSit-to-stand test for 30 seconds
Concentration of leptin in pg/mg1 yearblood ghrelin and leptin measurement
Lower limbs muscle strength1 yearLower limbs muscle strength will be evaluated with Biodex
Upper limbs muscle strength1 yearThe muscle strength of the upper limbs will be evaluated by manual pressure dynamometry (Handgrip)
Cardiorespiratory fitness1 year6-minute walk test (TC6)
HDL cholesterol in mg/dl1 yearBlood sample
Body weight1 yearWeight evaluation will be done using a scale
Height1 yearHeight evaluation will be done using a stadiometer
Abdominal circumference1 yearAbdominal circumference will be determined by a measuring tape
LDL cholesterol in mg/dl1 yearBlood sample
Triglycerides in mg/dl1 yearBlood sample
Glucose in mg/dl1 yearBlood sample
Insulin in µIU/mL1 yearBlood sample
Glycated hemoglobin in %1 yearBlood sample
Alcohol intake1 yearassessment of daily consumption through clinical data questionnaire
Mean blood pressure1 yearEvaluation with Sphygnomanonetro
Concentration of ghrelin in pg/mg1 yearblood ghrelin and leptin measurement

Secondary

MeasureTime frameDescription
Salivary amylase1 yearSaliva harvest
physical activity level1 yearAccelerometers measure body movement, providing objective information about the frequency, intensity and duration of physical activity
Glycemia Variation in mg/dl1 yearEvaluation continues through an implantable device for 5 days
Life Quality1 yearQuestionary BAROS as a self-report measure, validated for the Portuguese population specific for bariatric surgery

Countries

Portugal

Contacts

Primary ContactCláudia Amaro Dos Santos, PhD Student
cmendes@hevora.min-saude.pt968575053

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026